Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CHAR Technologies Recognized as a Top 50 TSX Venture Exchange Company
-
REE Automotive and Knapheide Debut Full Vehicle Solution
-
Daré Bioscience to Present at the International Society for the Study of Women’s Sexual Health (ISSWSH) Annual Meeting
-
Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment
-
OncoC4 Announces First Patient with Advanced Prostate Cancer Dosed in Phase 1/2 Trial of BioNTech-partnered BNT316/ONC-392 Program
-
Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds
-
Comscore Transforms Local and National Ad Campaigns with Pioneering Cross-Platform Audience Measurement
-
Pixalate Releases Global Q4 2023 Connected TV (CTV) Device Market Share Report: Roku Leads North America CTV Market Share of Voice (SOV) at 55%
-
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair
-
Vega Cloud Launches Partner Program for FinOps-focused Channel Companies
-
MedBright AI Announces Limmi Disease Insights Platform Being Used in University Hospital Setting to Improve Detection of Kidney Stone Disease Recurrence
-
ABM to Announce First Quarter 2024 Financial Results
-
Clene Reports Significant Survival Benefit With CNM-Au8® Treatment in ALS EAP Compassionate Use Programs
-
Apnimed to Participate in the Upcoming Evercore ISI 2024 Emerging Biotech Conference
-
IMNN-101 Preclinical Data in SARS CoV-2 Published in Peer-Reviewed Journal Vaccine
-
Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study
-
DMG Blockchain Solutions Announces Investment in Digital Asset Custody Solution
-
Tilray Brands, Owner of 5ᵗʰ Largest U.S. Craft Beer Business, Selects MicroStar Logistics as Long-Term Keg Supply Chain Partner
-
American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis
-
Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept “Tick-Kill” Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease
-
Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
-
Mexican Rail Operator Renews Support Contract and Adds Duos AI
-
La Rosa Acquires Seventh Real Estate Brokerage Franchisee with Revenue of $1.4 Million and Positive Cash Flow in 2023
-
BioAdaptives, Inc. Announces NaturaComplete™, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System
-
Comscore Transforms Local and National Ad Campaigns with Pioneering Cross-Platform Audience Measurement
-
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
-
Treasure Global and Silica-AI Forge Strategic Partnership to Revolutionize AI and IoT Landscape Across Southeast Asia
-
Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024
-
authID Inc. Announces Change to its Board of Directors for Next Phase of Growth
-
Fansee Embarks on a Revolutionary Path under the Leadership of Visionary CEO Jason Hung
-
Spectaire Announces New Demand by Canadian Trucking Fleets for Deployment of AireCore Technology in Response to Escalating Carbon Taxes
-
Verizon Business building highly customized private 5G environment for Audi AG automotive test track
-
Centessa Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference
-
Talkspace Announces Fourth Quarter and Full Year 2023 Results
-
GoHealth to Announce Fourth Quarter and Year End 2023 Results on March 14, 2024
-
Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses
-
Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update
-
Addressing Obesity in the Public Sector
-
Despite Seasonal Dip in Q4 2023, Insurance Shopping Likely to Remain Strong in 2024
-
Pacira to Report 2023 Financial Results on Thursday February 29, 2024
-
Medela Launches Innovative Smart Watch App for New Parents
-
Lisata Therapeutics to Host Year-End 2023 Conference Call on Thursday, February 29, 2024 at 4:30 p.m. Eastern Time
-
Notice of Nexstim Plc’s 2023 Full Year Results
-
Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™
-
Form 8.3 - [ SHANTA GOLD LIMITED - 21 02 2024] - (CGAML)
-
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
-
Form 8.3 - [ LONDONMETRIC PROPERTY PLC - 21 02 2024] - (CGWL)
-
ZyVersa Therapeutics Publishes New White Paper Detailing the Role of Inflammasomes and ASC Specks in Neurological Diseases, and Data Supporting Inflammasome ASC Inhibitor IC 100 as a Potential Therape
-
Save Foods: NTwo Off Filed US Patent Application to Reduce Greenhouse Gas Emissions in Wheat Production
-
Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them

